In head and neck cancer, mutations or reduced expression of the NF2 gene often result in abnormal nuclear translocation of YAP/TAZ, thereby activating oncogenic gene expression and correlating with increased tumor invasiveness and poor patient prognosis (Nouri et al., 2024). This evidence concerns the gene NF2 and neoplasm.